Quotes 5-day view Delayed Nyse
05/10/2022
05/11/2022
05/12/2022
05/13/2022
05/16/2022
Date
432.8(c)
431.73(c)
428.94(c)
438.89(c)
444.33 Last
1 047 203
925 137
1 065 727
838 485
195 550 Volume
+1.95% -0.25% -0.65% +2.32% +1.24% Change
Estimated financial data (e) (USD)
Sales 2022
92 988 M - -
Net income 2022
2 969 M - -
Net Debt 2022
6 396 M - -
P/E ratio 2022
18,7x
Yield 2022
0,69%
Sales 2023
101 B - -
Net income 2023
3 413 M - -
Net Debt 2023
5 354 M - -
P/E ratio 2023
16,1x
Yield 2023
0,76%
Capitalization
55 517 M 55 517 M -
EV / Sales 2022
0,67x
EV / Sales 2023
0,60x
Nbr of Employees
95 500
Free-Float
63,6%
Humana Inc. is one of the leading health insurance and complementary medical services companies in the United States. Revenues break down by activity as follows:
- health insurance services (96.1%): to recipients of government-sponsored plans, to groups of employers and individuals;
- services (2.4%): health care, primary care, home clinical care, health coaching services, prescription of drugs, pharmaceutical...
All news about HUMANA INC.
10:01a Humana's CenterWell Senior Primary Care Enters Joint Venture With Welsh, Carson, Anders.. MT
07:32a Humana's CenterWell Senior Primary Care and Welsh, Carson, Anderson & Stowe Announce Se.. BU
05/11 Humana To Acquire Swedish Assistance Provider For $15 Million MT
05/10 TRANSCRIPT : Humana Inc. Presents at Bank of America 2022 Healthcare Conference, May-10-20..CI
05/10 Humana Specialty Pharmacy Receives Prestigious National Patient Choice Award for Fifth .. BU
05/05 INSIDER SELL : HumanaMT
05/03 Skylight Health Group Executes Definitive Agreement to Buy NeighborMD to Expand in Flor.. MT
05/02 INSIDER SELL : HumanaMT
05/02 INSIDER SELL : HumanaMT
04/28 Humana Inc. to Present at the BofA Securities 2022 Healthcare Conference BU
04/28 JPMorgan Lowers Humana's Price Target to $500 From $514, Maintains Overweight Rating MT
04/28 Wells Fargo Raises Humana's Price Target to $512 From $491, Maintains Overweight Rating MT
04/28 SVB Leerink Raises Humana's Price Target to $535 From $525, Maintains Outperform Rating MT
04/28 UBS Adjusts Humana Price Target to $532 From $520, Maintains Buy Rating MT
04/28 RBC Raises Price Target on Humana to $541 From $525, Maintains Outperform Rating MT
News in other languages on HUMANA INC.
Analyst Recommendations on HUMANA INC.
UnitedHealth to sell Change Healthcare's claims business for $2.2 bln
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends HUMANA INC.
Short Term Mid-Term Long Term Trends Bearish Neutral Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
22
Last Close Price
438,89 $
Average target price
501,60 $
Spread / Average Target
14,3%
Please enable JavaScript in your browser's settings to use dynamic charts.
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Report
